1.
|
Phase: Phase III, Phase II
Type: Supportive care
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014899, JNS020QD-JPN-C02, FENPAI2003, NCT00644787
|
|
2.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and older
Sponsor: NCI
Protocol IDs: NCCTG-889252, MAYO-889252, NCI-P91-0015
|
|
3.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: C25608/3039/BP/US, NCT00105287
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: 099-15, NCT00105937
|
|
5.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: ZMF-301, NCT00126789
|
|
6.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EN3267-005, NCT00262678
|
|
7.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FEN-202, NCT00293020
|
|
8.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FEN-201, NCT00293033
|
|
9.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: FT-018-IM, 2005-002348-24, NCT00362583
|
|
10.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPO43/06/FCNS, NCT00459277
|
|
11.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FT-019-IM, 2006-002087-26, NCT00496392
|
|
12.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014896, NCT00641667
|
|
13.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 3 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: C8278/2022/BP/US-CA, NCT00236093
|
|
14.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: FT-017-IM, 2005-002347-82, NCT00345735
|
|
15.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 3 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: C8278b/202/BP/US-CA, NCT00236041
|
|
16.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 20 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2246-0401, NCT00355628
|
|
17.
|
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: YALE-HIC-8358, NCI-V96-0817
|
|
18.
|
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 to 79
Sponsor: Other
Protocol IDs: YALE-HIC-8356, NCI-V96-0818
|
|
19.
|
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: YALE-HIC-8357, NCI-V96-0819
|
|
20.
|
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Closed
Age: no age specified
Sponsor: Other
Protocol IDs: RPCI-DS-92-13, NCI-V97-1251, NCT00003000
|
|
21.
|
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-84-C-131A, NCI-T84-0424, T84-0424
|
|
22.
|
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-82-C-20
|
|
23.
|
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 2 to 18
Sponsor: Other
Protocol IDs: 2003-0470, NCT00214370
|
|
24.
|
Phase: No phase specified
Type: Supportive care, Treatment
Status: Temporarily closed
Age: Not specified
Sponsor: NCI
Protocol IDs: RPCI-I-37404, I 37404, NCT00538499
|
